Multiple organ toxicity due to sintilimab
10.3760/cma.j.cn114015-20201207-01218
- VernacularTitle:信迪利单抗致多器官毒性反应
- Author:
Yiling GAO
1
;
Minghui ZHU
;
Qiaoyun TANG
;
Tong NI
;
Lin WANG
;
Jing MA
Author Information
1. 东南大学医学院附属南京同仁医院药学部，南京 211102
- Publication Type:Journal Article
- Keywords:
Antineoplastic agents, immunological;
Mufltiple organ failure;
Chemical and drug induced liver Iinjury;
Acute kidney injury;
Sintilimab
- From:
Adverse Drug Reactions Journal
2021;23(7):387-389
- CountryChina
- Language:Chinese
-
Abstract:
A 38-year-old female patient with recurrence of breast cancer accompanied by liver metastasis received intravenous infusion of sintilimab 200 mg on the first day and 21 days was a cycle. Before the immunotherapy, her function of liver, kidney, and thyroid was normal. Three days after the medication, the patient developed rash and itching on skin of waist. After that, diffuse erythema and desquamation appeared on skin of her whole body and blisters appeared on both upper limbs and back. At the same time, she developed blurred vision, increased eye secretions, and foreign-body sensation. Laboratory tests showed alanine aminotransferase (ALT) 123 U/L, aspartate aminotransferase (AST) 342 UL, γ-Glutamyltransferase (γ-GT) 907 U/L, alkaline phosphatase (ALP) 424 U/L, serum creatinine (Scr) 95.6 μmol/L, uric acid 691.0 μmol/L, and thyroid-stimulating hormone (TSH) 20.87 mU/L. She was diagnosed with rash, hypothyroidism, kidney injury, conjunctivitis, and liver injury, which were considered to be associated with sintilimab. After 16 days of symptomatic treatments such as IV infusions of methylprednisolone sodium succinate for injection and magnesium isoglycyrrhizinate injection, oral administration of levothyroxine sodium and Haikun Shenxi capsules (海昆肾喜胶囊), levofloxacin eye drops, and skin care, her rash was subsided, blisters were absorbed, and the discomfort in the eyes disappeared. Laboratory tests showed ALT 111 UL, AST 122 U/L, γ-GT 1 430 U/L, ALP 321 U/L, Scr 56.0 μmol/L, uric acid 243.0 μmol/L, and TSH 13.60 mU/L.
